María Elena Hernández-Aguilar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
María Elena Hernández-Aguilar has a total of 206 co-authors. Here are the top co-authors by number of shared publications:
- Jorge Manzo
Universidad Veracruzana
66 shared publications - Deissy Herrera-Covarrubias
Instituto de Investigaciones Cerebrales, Universidad Veracruzana, Xalapa 91190, Mexico
49 shared publications - Gonzalo Emiliano Aranda-Abreu
Instituto de Investigaciones Cerebrales, Universidad Veracruzana, Xalapa 91190, Mexico
45 shared publications - Fausto Rojas-Durán
Instituto de Investigaciones Cerebrales, Universidad Veracruzana
43 shared publications - Luis Isauro García
Instituto de Investigaciones Cerebrales, Universidad Veracruzana, Xalapa 91190, Veracruz, Mexico
38 shared publications - Genaro Alfonoso Coria Ávila
Universidad Veracruzana
34 shared publications
Latest Publications
- Open Access
Involvement of Prolactin in Cancer Cell Migration
Prolactin (PRL) is a hormone synthesized by lactotrophs in the anterior pituitary gland. It is also produced by extrapituitary glands such as the prostate and breast, where it promotes growth. Notably, PRL also contributes to cancer development in these glands. PRL is known to stimulate cancer cell migration, suggesting its possible involvement in metastasis, for which cell migration is a critical step. However, the role and mechanisms by which PRL induces cancer cell migration are not yet fully understood. One well-studied mechanism involves its receptor, the prolactin receptor (PRLR). After PRL binds to its receptor, PRLR dimerizes and induces transphosphorylation of Janus kinase 2 (JAK2), which subsequently phosphorylates p21-activated kinase 1 (PAK1), leading to increased cell migration. Although the PRL-JAK2-PAK1 pathway in cancer cell migration has been investigated, the molecular mechanism remains incompletely understood. Additionally, other PRL-activated pathways are implicated in migration, but their roles remain debated. This narrative review examines and discusses the main findings on the involvement of PRL in the migration of cancerous and non-cancerous cells, as well as the molecular mechanisms involved. We conclude that PRL promotes the migration of both cancerous and non-cancerous cell lines and should, therefore, be taken into account in future cancer research.
Open AccessInvolvement of Prolactin in Cancer Cell Migration
Prolactin (PRL) is a hormone synthesized by lactotrophs in the anterior pituitary gland. It is also produced by extrapituitary glands such as the prostate and breast, where it promotes growth. Notably, PRL also contributes to cancer development in these glands. PRL is known to stimulate cancer cell migration, suggesting its possible involvement in metastasis, for which cell migration is a critical step. However, the role and mechanisms by which PRL induces cancer cell migration are not yet fully understood. One well-studied mechanism involves its receptor, the prolactin receptor (PRLR). After PRL binds to its receptor, PRLR dimerizes and induces transphosphorylation of Janus kinase 2 (JAK2), which subsequently phosphorylates p21-activated kinase 1 (PAK1), leading to increased cell migration. Although the PRL-JAK2-PAK1 pathway in cancer cell migration has been investigated, the molecular mechanism remains incompletely understood. Additionally, other PRL-activated pathways are implicated in migration, but their roles remain debated. This narrative review examines and discusses the main findings on the involvement of PRL in the migration of cancerous and non-cancerous cells, as well as the molecular mechanisms involved. We conclude that PRL promotes the migration of both cancerous and non-cancerous cell lines and should, therefore, be taken into account in future cancer research.
- Open Access
Environmental Enrichment Exerts a Selective, Stage-Dependent Modulation on the Autism-like Behavioral Phenotype Induced by Embryonic Valproic Acid in Zebrafish
Autism Spectrum Disorder (ASD) is characterized by deficits in communication, socialization, and restricted behavioral patterns. Valproic acid (VPA) is a teratogen that, through epigenetic mechanisms, induces ASD-like phenotypes in animal models. The zebrafish (Danio rerio) represents an ideal model for evaluating these alterations due to its complex behavioral repertoire. This study analyzed the longitudinal effect of an enriched environment (EE) on VPA-induced behavioral alterations in juvenile and adult stages (n = 72; n = 18 per group: CTRL-SE, CTRL-EE, VPA-SE, and VPA-EE). Subjects were evaluated across the novel tank, mirror test, and social interaction tests. The results reveal a selective, stage-dependent modulation: in the novel tank test, VPA fish housed in EE presented a significant reduction in erratic movements (stereotypies) and increased time spent in the upper zone (reduced anxiety), whereas specific modifications in shoal approach were observed in the social interaction test. These modulating effects were evident from the juvenile stage and consolidated in adulthood across specific locomotor and exploratory metrics. It is concluded that the enriched environment may act as a neuromodulatory strategy capable of mitigating selective aspects of the autism-like behavioral phenotype in zebrafish.
Open AccessEnvironmental Enrichment Exerts a Selective, Stage-Dependent Modulation on the Autism-like Behavioral Phenotype Induced by Embryonic Valproic Acid in Zebrafish
Autism Spectrum Disorder (ASD) is characterized by deficits in communication, socialization, and restricted behavioral patterns. Valproic acid (VPA) is a teratogen that, through epigenetic mechanisms, induces ASD-like phenotypes in animal models. The zebrafish (Danio rerio) represents an ideal model for evaluating these alterations due to its complex behavioral repertoire. This study analyzed the longitudinal effect of an enriched environment (EE) on VPA-induced behavioral alterations in juvenile and adult stages (n = 72; n = 18 per group: CTRL-SE, CTRL-EE, VPA-SE, and VPA-EE). Subjects were evaluated across the novel tank, mirror test, and social interaction tests. The results reveal a selective, stage-dependent modulation: in the novel tank test, VPA fish housed in EE presented a significant reduction in erratic movements (stereotypies) and increased time spent in the upper zone (reduced anxiety), whereas specific modifications in shoal approach were observed in the social interaction test. These modulating effects were evident from the juvenile stage and consolidated in adulthood across specific locomotor and exploratory metrics. It is concluded that the enriched environment may act as a neuromodulatory strategy capable of mitigating selective aspects of the autism-like behavioral phenotype in zebrafish.
- Open Access
- 21 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 766
Autism and Neurodegeneration: Distinct Disorders or a Shared Biological Continuum?
Background/Objectives: Autism spectrum disorder (ASD) is traditionally classified as a neurodevelopmental condition, whereas neurodegenerative diseases are defined by progressive neuronal decline in later life. This separation has shaped research and clinical practice, yet emerging evidence suggests potential biological overlap. This review aims to evaluate whether ASD and neurodegenerative disorders represent distinct entities or are linked through shared mechanisms operating across the lifespan. Methods: This narrative review synthesizes findings from genetic, molecular, cellular, circuit-level, and epidemiological studies examining ASD and major neurodegenerative conditions, including Alzheimer’s disease, Parkinson’s disease, and Amyotrophic lateral sclerosis. Emphasis is placed on identifying convergent pathways and evaluating evidence within a lifespan-oriented framework. Results: Across multiple levels of analysis, ASD and neurodegenerative diseases share partially overlapping biological mechanisms, including mitochondrial dysfunction, impaired proteostasis, neuroimmune alterations, and network-level instability. Genetic and molecular data reveal pleiotropic pathways influencing both early neurodevelopment and later neuronal resilience. Circuit-level studies highlight shared principles of network vulnerability, including cerebellar involvement and excitation–inhibition imbalance. Epidemiological data further indicate increased risk of dementia and parkinsonian features in autistic adults. These convergences suggest that early neurodevelopmental alterations may establish latent vulnerabilities that, under specific conditions, intersect with neurodegenerative processes later in life. Conclusions: ASD and neurodegenerative diseases are best understood as distinct clinical conditions that share partially overlapping biological substrates. Rather than implying a deterministic progression, the evidence supports a model of lifespan convergence in which timing, context, and individual susceptibility shape outcomes. This framework highlights the need for integrated research and clinical approaches that consider brain health as a continuous process from development through aging.
- 21 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (7) , 766
Open AccessAutism and Neurodegeneration: Distinct Disorders or a Shared Biological Continuum?
Background/Objectives: Autism spectrum disorder (ASD) is traditionally classified as a neurodevelopmental condition, whereas neurodegenerative diseases are defined by progressive neuronal decline in later life. This separation has shaped research and clinical practice, yet emerging evidence suggests potential biological overlap. This review aims to evaluate whether ASD and neurodegenerative disorders represent distinct entities or are linked through shared mechanisms operating across the lifespan. Methods: This narrative review synthesizes findings from genetic, molecular, cellular, circuit-level, and epidemiological studies examining ASD and major neurodegenerative conditions, including Alzheimer’s disease, Parkinson’s disease, and Amyotrophic lateral sclerosis. Emphasis is placed on identifying convergent pathways and evaluating evidence within a lifespan-oriented framework. Results: Across multiple levels of analysis, ASD and neurodegenerative diseases share partially overlapping biological mechanisms, including mitochondrial dysfunction, impaired proteostasis, neuroimmune alterations, and network-level instability. Genetic and molecular data reveal pleiotropic pathways influencing both early neurodevelopment and later neuronal resilience. Circuit-level studies highlight shared principles of network vulnerability, including cerebellar involvement and excitation–inhibition imbalance. Epidemiological data further indicate increased risk of dementia and parkinsonian features in autistic adults. These convergences suggest that early neurodevelopmental alterations may establish latent vulnerabilities that, under specific conditions, intersect with neurodegenerative processes later in life. Conclusions: ASD and neurodegenerative diseases are best understood as distinct clinical conditions that share partially overlapping biological substrates. Rather than implying a deterministic progression, the evidence supports a model of lifespan convergence in which timing, context, and individual susceptibility shape outcomes. This framework highlights the need for integrated research and clinical approaches that consider brain health as a continuous process from development through aging.
- 10 June 2026
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 232, 112211
Alternative splicing in Alzheimer’s disease: Driver, modifier, or consequence of neurodegeneration
- 10 June 2026
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 232, 112211
Alternative splicing in Alzheimer’s disease: Driver, modifier, or consequence of neurodegeneration
- 4 May 2026
- Published by Taylor & Francis in Future Virology
- Vol. 21 (5) , 351-363
Five years of SARS-CoV-2 evolution: variants, mechanisms, and public health challenges
1. SARS-CoV-2, the causative agent of the COVID-19 pandemic, was first identified in December 2019 in the city of Wuhan, China [1,2]. This marked the beginning of a global health crisis unprecedent...
- 4 May 2026
- Published by Taylor & Francis in Future Virology
- Vol. 21 (5) , 351-363
Five years of SARS-CoV-2 evolution: variants, mechanisms, and public health challenges
1. SARS-CoV-2, the causative agent of the COVID-19 pandemic, was first identified in December 2019 in the city of Wuhan, China [1,2]. This marked the beginning of a global health crisis unprecedent...
- Open Access
Cytostatic and Pro-Apoptotic Effects of Justicia spicigera Schltdl. on LNCaP Prostate Cancer Cells: Role of G0/G1 Cell Cycle Arrest and Phytochemical Characterization
Justicia spicigera is a central medicinal plant in Mexican ethnomedicine, yet its therapeutic potential against prostate cancer remains largely unexplored. This study investigated the antiproliferative and pro-apoptotic effects of a 50% hydroalcoholic extract from the leaves and stems of J. spicigera on androgen-sensitive LNCaP prostate cancer cells. Phytochemical profiling via thin layer chromatography (TLC) and LC-MS putatively identified the bioactive flavonoid kaempferitrin within the complex extract. Biological assays, including MTT, trypan blue exclusion, and flow cytometry, revealed that the extract inhibits LNCaP proliferation in a distinct, dose-dependent manner. At a lower concentration (250 µg/mL), the extract exerted a primarily cytostatic effect by inducing significant G0/G1 cell cycle arrest without triggering immediate cell death. Conversely, higher concentrations (≥500 µg/mL) were potently cytotoxic, reducing cell viability to below 20% and inducing late apoptosis in approximately 58% of the population within 24 h. These results validate the in vitro biological activity of J. spicigera in a specific prostate cancer model. While the concentrations required for cytotoxicity are relatively high, the observed dose-dependent G0/G1 arrest provides a foundational phenotypic profile for this traditional extract, warranting further investigation into its selectivity and potential as a bioactive scaffold.
Open AccessCytostatic and Pro-Apoptotic Effects of Justicia spicigera Schltdl. on LNCaP Prostate Cancer Cells: Role of G0/G1 Cell Cycle Arrest and Phytochemical Characterization
Justicia spicigera is a central medicinal plant in Mexican ethnomedicine, yet its therapeutic potential against prostate cancer remains largely unexplored. This study investigated the antiproliferative and pro-apoptotic effects of a 50% hydroalcoholic extract from the leaves and stems of J. spicigera on androgen-sensitive LNCaP prostate cancer cells. Phytochemical profiling via thin layer chromatography (TLC) and LC-MS putatively identified the bioactive flavonoid kaempferitrin within the complex extract. Biological assays, including MTT, trypan blue exclusion, and flow cytometry, revealed that the extract inhibits LNCaP proliferation in a distinct, dose-dependent manner. At a lower concentration (250 µg/mL), the extract exerted a primarily cytostatic effect by inducing significant G0/G1 cell cycle arrest without triggering immediate cell death. Conversely, higher concentrations (≥500 µg/mL) were potently cytotoxic, reducing cell viability to below 20% and inducing late apoptosis in approximately 58% of the population within 24 h. These results validate the in vitro biological activity of J. spicigera in a specific prostate cancer model. While the concentrations required for cytotoxicity are relatively high, the observed dose-dependent G0/G1 arrest provides a foundational phenotypic profile for this traditional extract, warranting further investigation into its selectivity and potential as a bioactive scaffold.
- Open Access
Antitumor Mechanisms of Pulsed Electromagnetic Fields in Cancer Cells: A Review of Molecular and Cellular Evidence
Cancer remains a significant global health burden, often requiring conventional treatments characterized by considerable side effects and limited tumor specificity. This review addresses the critical gap in understanding the non-thermal mechanisms by which Pulsed Electromagnetic fields (PEMFs) exert selective anti-tumor effects. Our primary objective is to analyze the molecular and cellular events through which low-intensity PEMF triggers stress responses and apoptosis in neoplastic cells without impacting normal cell viability. This comprehensive review synthesizes current evidence on the biological effects of PEMFs. Findings indicate that PEMFs disrupts intracellular homeostasis, induces reactive oxygen species-mediated oxidative stress, and activates endoplasmic reticulum stress, collectively driving malignant cells towards apoptosis or cell cycle arrest. Importantly, these effects are preferentially observed in cancer cells due to their inherent biophysical vulnerabilities—such as depolarized membrane potentials—and depend critically on specific PEMFs parameters. In conclusion, PEMFs acts as a multifaceted disruptor of cancer cell homeostasis, representing a promising non-invasive therapeutic modality. Further research is essential to optimize dosimetry and identify primary molecular sensors such as radical pair dynamics, to enhance clinical application and explore synergistic combinations with existing therapies.
Open AccessAntitumor Mechanisms of Pulsed Electromagnetic Fields in Cancer Cells: A Review of Molecular and Cellular Evidence
Cancer remains a significant global health burden, often requiring conventional treatments characterized by considerable side effects and limited tumor specificity. This review addresses the critical gap in understanding the non-thermal mechanisms by which Pulsed Electromagnetic fields (PEMFs) exert selective anti-tumor effects. Our primary objective is to analyze the molecular and cellular events through which low-intensity PEMF triggers stress responses and apoptosis in neoplastic cells without impacting normal cell viability. This comprehensive review synthesizes current evidence on the biological effects of PEMFs. Findings indicate that PEMFs disrupts intracellular homeostasis, induces reactive oxygen species-mediated oxidative stress, and activates endoplasmic reticulum stress, collectively driving malignant cells towards apoptosis or cell cycle arrest. Importantly, these effects are preferentially observed in cancer cells due to their inherent biophysical vulnerabilities—such as depolarized membrane potentials—and depend critically on specific PEMFs parameters. In conclusion, PEMFs acts as a multifaceted disruptor of cancer cell homeostasis, representing a promising non-invasive therapeutic modality. Further research is essential to optimize dosimetry and identify primary molecular sensors such as radical pair dynamics, to enhance clinical application and explore synergistic combinations with existing therapies.
- Top Cited PapersOpen Access
- 20 February 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (2) , 37
Alzheimer’s Disease as a Disorder of Neuroimmune Dysregulation
Alzheimer’s disease (AD) is traditionally defined by Amyloid-β (Aβ) plaques and tau neurofibrillary tangles, yet these proteinopathies alone fail to explain disease heterogeneity, progression, and cognitive decline. Emerging evidence identifies chronic neuroinflammation as a central integrator that converts molecular pathology into synaptic failure and neurodegeneration. In this context, Aβ acts as a danger-associated molecular pattern that activates microglial and astrocytic immune programs through receptors such as TREM2, TLRs, and RAGE, leading to inflammasome activation, cytokine release, and oxidative stress. These responses pathologically re-engage developmental complement pathways (C1q–C3–CR3), driving excessive synaptic pruning that correlates more closely with cognitive impairment than neuronal loss. Reactive astrocytes further amplify dysfunction by impairing glutamate and potassium homeostasis, promoting excitotoxic and metabolic stress, while inflammatory glia facilitate prion-like tau propagation via extracellular vesicles. Concurrent neurovascular inflammation disrupts blood–brain barrier integrity and cerebral perfusion, reinforcing immune-metabolic failure. Importantly, neuroinflammatory biomarkers (GFAP, sTREM2, YKL-40, cytokines, complement, and TSPO-PET) provide dynamic readouts of disease activity and therapeutic response. Together, these findings position AD as a disorder of failed immune resolution and support precision immunomodulatory and pro-resolving therapies aimed at restoring neuroimmune homeostasis rather than merely removing protein aggregates.
- 20 February 2026
- Published by MDPI AG in Neurology International
- Vol. 18 (2) , 37
Top Cited PapersOpen AccessAlzheimer’s Disease as a Disorder of Neuroimmune Dysregulation
Alzheimer’s disease (AD) is traditionally defined by Amyloid-β (Aβ) plaques and tau neurofibrillary tangles, yet these proteinopathies alone fail to explain disease heterogeneity, progression, and cognitive decline. Emerging evidence identifies chronic neuroinflammation as a central integrator that converts molecular pathology into synaptic failure and neurodegeneration. In this context, Aβ acts as a danger-associated molecular pattern that activates microglial and astrocytic immune programs through receptors such as TREM2, TLRs, and RAGE, leading to inflammasome activation, cytokine release, and oxidative stress. These responses pathologically re-engage developmental complement pathways (C1q–C3–CR3), driving excessive synaptic pruning that correlates more closely with cognitive impairment than neuronal loss. Reactive astrocytes further amplify dysfunction by impairing glutamate and potassium homeostasis, promoting excitotoxic and metabolic stress, while inflammatory glia facilitate prion-like tau propagation via extracellular vesicles. Concurrent neurovascular inflammation disrupts blood–brain barrier integrity and cerebral perfusion, reinforcing immune-metabolic failure. Importantly, neuroinflammatory biomarkers (GFAP, sTREM2, YKL-40, cytokines, complement, and TSPO-PET) provide dynamic readouts of disease activity and therapeutic response. Together, these findings position AD as a disorder of failed immune resolution and support precision immunomodulatory and pro-resolving therapies aimed at restoring neuroimmune homeostasis rather than merely removing protein aggregates.
- Open Access
- 5 February 2026
- Published by Elsevier in Physiology & Behavior
- Vol. 308, 115261
Prenatal, but not neonatal, paracetamol exposure disrupts neuroendocrine regulation of stress and emotional behavior in adult male rats
- 5 February 2026
- Published by Elsevier in Physiology & Behavior
- Vol. 308, 115261
Open AccessPrenatal, but not neonatal, paracetamol exposure disrupts neuroendocrine regulation of stress and emotional behavior in adult male rats
- Open Access
- 22 January 2026
- Published by MDPI AG in Preprints.org
Cytostatic and Pro-Apoptotic Effects of Justicia spicigera Schltdl. on LNCaP Prostate Cancer Cells: Role of G0/G1 Cell Cycle Arrest and Phytochemical Characterization
Justicia spicigera is a central medicinal plant in Mexican ethnomedicine, yet its therapeutic potential against prostate cancer remains largely unexplored. This study investigated the antiproliferative and pro-apoptotic effects of a 50% hydroalcoholic extract from the leaves and stems of J. spicigera on androgen-sensitive LNCaP prostate cancer cells. Phytochemical profiling via TLC and LC-MS putatively identified the bioactive flavonoid kaempferitrin within the complex extract. Biological assays, including MTT, trypan blue exclusion, and flow cytometry, revealed that the extract inhibits LNCaP proliferation in a distinct, dose-dependent manner. At a lower concentration (250 µg/mL), the extract exerted a primarily cytostatic effect by inducing significant G0/G1 cell cycle arrest without triggering immediate cell death. Conversely, higher concentrations (≥500 µg/mL) were potently cytotoxic, reducing cell viability to below 20% and inducing late apoptosis in approximately 58% of the population within 24 hours. These results validate the biological activity of J. spicigera in a prostate cancer model and suggest that the extract, or its constituent flavonoids could serve as a template for developing treatments that target both cell cycle checkpoints and programmed cell death.
- 22 January 2026
- Published by MDPI AG in Preprints.org
Open AccessCytostatic and Pro-Apoptotic Effects of Justicia spicigera Schltdl. on LNCaP Prostate Cancer Cells: Role of G0/G1 Cell Cycle Arrest and Phytochemical Characterization
Justicia spicigera is a central medicinal plant in Mexican ethnomedicine, yet its therapeutic potential against prostate cancer remains largely unexplored. This study investigated the antiproliferative and pro-apoptotic effects of a 50% hydroalcoholic extract from the leaves and stems of J. spicigera on androgen-sensitive LNCaP prostate cancer cells. Phytochemical profiling via TLC and LC-MS putatively identified the bioactive flavonoid kaempferitrin within the complex extract. Biological assays, including MTT, trypan blue exclusion, and flow cytometry, revealed that the extract inhibits LNCaP proliferation in a distinct, dose-dependent manner. At a lower concentration (250 µg/mL), the extract exerted a primarily cytostatic effect by inducing significant G0/G1 cell cycle arrest without triggering immediate cell death. Conversely, higher concentrations (≥500 µg/mL) were potently cytotoxic, reducing cell viability to below 20% and inducing late apoptosis in approximately 58% of the population within 24 hours. These results validate the biological activity of J. spicigera in a prostate cancer model and suggest that the extract, or its constituent flavonoids could serve as a template for developing treatments that target both cell cycle checkpoints and programmed cell death.